Literature DB >> 25449277

SAMHD1 is down regulated in lung cancer by methylation and inhibits tumor cell proliferation.

Jia-lei Wang1, Fan-zhen Lu2, Xiao-Yong Shen3, Yun Wu4, Li-ting Zhao2.   

Abstract

The function of dNTP hydrolase SAMHD1 as a viral restriction factor to inhibit the replication of several viruses in human immune cells was well established. However, its regulation and function in lung cancer have been elusive. Here, we report that SAMHD1 is down regulated both on protein and mRNA levels in lung adenocarcinoma compared to adjacent normal tissue. We also found that SAMHD1 promoter is highly methylated in lung adenocarcinoma, which may inhibit its gene expression. Furthermore, over expression of the SAMHD1 reduces dNTP level and inhibits the proliferation of lung tumor cells. These results reveal the regulation and function of SAMHD1 in lung cancer, which is important for the proliferation of lung tumor cells.
Copyright © 2014 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Cell proliferation; Lung adenocarcinoma; SAMHD1; dNTP

Mesh:

Substances:

Year:  2014        PMID: 25449277     DOI: 10.1016/j.bbrc.2014.10.153

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  33 in total

1.  The SAMHD1 dNTP Triphosphohydrolase Is Controlled by a Redox Switch.

Authors:  Christopher H Mauney; LeAnn C Rogers; Reuben S Harris; Larry W Daniel; Nelmi O Devarie-Baez; Hanzhi Wu; Cristina M Furdui; Leslie B Poole; Fred W Perrino; Thomas Hollis
Journal:  Antioxid Redox Signal       Date:  2017-04-18       Impact factor: 8.401

2.  Exogenous expression of SAMHD1 inhibits proliferation and induces apoptosis in cutaneous T-cell lymphoma-derived HuT78 cells.

Authors:  Karthik M Kodigepalli; Minghua Li; Shan-Lu Liu; Li Wu
Journal:  Cell Cycle       Date:  2016-12-08       Impact factor: 4.534

3.  Targeting SAMHD1 with the Vpx protein to improve cytarabine therapy for hematological malignancies.

Authors:  Nikolas Herold; Sean G Rudd; Linda Ljungblad; Kumar Sanjiv; Ida Hed Myrberg; Cynthia B J Paulin; Yaser Heshmati; Anna Hagenkort; Juliane Kutzner; Brent D G Page; José M Calderón-Montaño; Olga Loseva; Ann-Sofie Jemth; Lorenzo Bulli; Hanna Axelsson; Bianca Tesi; Nicholas C K Valerie; Andreas Höglund; Julia Bladh; Elisée Wiita; Mikael Sundin; Michael Uhlin; Georgios Rassidakis; Mats Heyman; Katja Pokrovskaja Tamm; Ulrika Warpman-Berglund; Julian Walfridsson; Sören Lehmann; Dan Grandér; Thomas Lundbäck; Per Kogner; Jan-Inge Henter; Thomas Helleday; Torsten Schaller
Journal:  Nat Med       Date:  2017-01-09       Impact factor: 53.440

4.  MicroRNA-181 contributes to downregulation of SAMHD1 expression in CD4+ T-cells derived from Sèzary syndrome patients.

Authors:  Rebecca Kohnken; Karthik M Kodigepalli; Anjali Mishra; Pierluigi Porcu; Li Wu
Journal:  Leuk Res       Date:  2016-11-17       Impact factor: 3.156

5.  SAMHD1 inhibits epithelial cell transformation in vitro and affects leukemia development in xenograft mice.

Authors:  Karthik M Kodigepalli; Minghua Li; Serena Bonifati; Amanda R Panfil; Patrick L Green; Shan-Lu Liu; Li Wu
Journal:  Cell Cycle       Date:  2018-12-04       Impact factor: 4.534

6.  Single-Stranded Nucleic Acids Bind to the Tetramer Interface of SAMHD1 and Prevent Formation of the Catalytic Homotetramer.

Authors:  Kyle J Seamon; Namandjé N Bumpus; James T Stivers
Journal:  Biochemistry       Date:  2016-10-27       Impact factor: 3.162

7.  SAMHD1 modulates in vitro proliferation of acute myeloid leukemia-derived THP-1 cells through the PI3K-Akt-p27 axis.

Authors:  Karthik M Kodigepalli; Serena Bonifati; Nagaraja Tirumuru; Li Wu
Journal:  Cell Cycle       Date:  2018-07-17       Impact factor: 4.534

8.  SAMHD1 controls cell cycle status, apoptosis and HIV-1 infection in monocytic THP-1 cells.

Authors:  Serena Bonifati; Michele B Daly; Corine St Gelais; Sun Hee Kim; Joseph A Hollenbaugh; Caitlin Shepard; Edward M Kennedy; Dong-Hyun Kim; Raymond F Schinazi; Baek Kim; Li Wu
Journal:  Virology       Date:  2016-05-14       Impact factor: 3.616

Review 9.  SAMHD1: Recurring roles in cell cycle, viral restriction, cancer, and innate immunity.

Authors:  Christopher H Mauney; Thomas Hollis
Journal:  Autoimmunity       Date:  2018-03-27       Impact factor: 2.815

10.  Toxicity and Pharmacokinetic Studies of Aerosolized Clinical Grade Azacitidine.

Authors:  Xuan Qiu; Yuanxin Liang; Rani S Sellers; Roman Perez-Soler; Yiyu Zou
Journal:  Clin Lung Cancer       Date:  2015-10-22       Impact factor: 4.785

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.